Patent · US Active

Salt of LSD1 inhibitor and a polymorph thereof

US12024494B2 · kind B2 · utility

0Cited by

3References

7Claims

0Family size

Assignee

CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. · CN

Inventors

Lele ZHAO · Shanghai, CN
Jianjun SUN · Zhaoqing, CN
Lingyun WU · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Jul 19, 2019
Grant date	Jul 2, 2024
Priority date	—
Expiry date	Jul 25, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a compound III serving as an LSD1 inhibitor and a crystal form thereof, as well as use of the compound and the crystal form thereof in preparation of a medicament for treating an LSD1 related disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.